(Q34418391)

2 August 2017

1 reference

title

Cancer risk associated with receipt of vaccines contaminated with simian virus 40: epidemiologic research (English)

1 reference

2 August 2017

simian virus 40

1 reference

Eric A Engels

1

1 reference

2 August 2017

publication date

1 April 2005

1 reference

Expert Review of Vaccines

2 August 2017

published in

1 reference

2 August 2017

volume

4

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

197-206

1 reference

The vacuolating virus, S.V. 40

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Identification of the oncogenic substance in rhesus monkey kidney cell culture as simian virus 40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Association between simian virus 40 and non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Association between simian virus 40 DNA and lymphoma in the United kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Absence of simian virus 40 in human brain tumors from northern India

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

An evaluation of the carcinogenicity of simian virus 40 in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Poliovirus vaccination during pregnancy, maternal seroconversion to simian virus 40, and risk of childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Live oral poliovirus vaccines do not contain detectable simian virus 40 (SV40) DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Examination of poliovirus vaccine preparations for SV40 sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Thirty-five year mortality following receipt of SV40- contaminated polio vaccine during the neonatal period

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Investigation of leukemia cells from children with common acute lymphoblastic leukemia for genomic sequences of the primate polyomaviruses JC virus, BK virus, and simian virus 40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Case-control study of cancer among US Army veterans exposed to simian virus 40-contaminated adenovirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Simian virus 40 (SV40) and human cancer: a review of the serological data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Documenting the epidemiologic patterns of polyomaviruses in human populations by studying their presence in urban sewage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Investigation of human urine for genomic sequences of the primate polyomaviruses simian virus 40, BK virus, and JC virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Lack of serological evidence for an association between simian virus 40 and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Antibody responses to simian virus 40 T antigen: a case-control study of non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

DETECTION OF SPECIFIC ANTIGEN IN SV40-TRANSFORMED CELLS BY IMMUNOFLUORESCENCE

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Leukemia, lymphoma, and osteosarcoma induced in the Syrian golden hamster by simian virus 40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Immunohistochemical investigation of SV40 large T antigen in Hodgkin and non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Childhood exposure to simian virus 40-contaminated poliovirus vaccine and risk of AIDS-associated non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.2.197

21 January 2018

Identifiers

DOI

10.1586/14760584.4.2.197

1 reference

2 August 2017

1 reference